CrackitToday App

Tirzepatide : Weight Loss Drug

Kumari Sonali

Tirzepatide : Weight Loss Drug

India is set to approve the weight-loss drug tirzepatide marking a significant advancement in obesity treatment.

  • This follows global trends where drugs like semaglutide (Ozempic and Wegovy) have shown dramatic weight loss effects.
  • Tirzepatide, originally approved for diabetes, also induces weight loss by boosting hormones GLP-1 and GIP, which promote satiety and manage glucose levels.
  • Clinical trials have demonstrated substantial weight loss with tirzepatide, with participants losing up to 20.9% of their body weight.
  • However, ongoing use is necessary to maintain these results, as stopping the medication leads to weight regain.
    Side effects include nausea, vomiting, and risk of thyroid tumours.

...Read more on our test console

...Read these too

  • Donanemab : New Alzheimer’s Drug

    Donanemab : New Alzheimer’s Drug A new Alzheimer’s drug, donanemab, has received support from an FDA advisory committee, moving closer to approval. Intended for early-stage Alzheimer’s, it shows significant slowing…

  • Loss And Damage Board

    Loss And Damage Board: Developed countries have delayed nominating members to the Loss and Damage Board, hampering efforts to fully operationalise the fund to developing countries in time. Loss and…

  • Cryosphere Loss

    Cryosphere Loss: At COP27, a broad coalition of 18 governments joined together to create a new high-level group ‘Ambition on Melting Ice (AMI) on Sea-level Rise and Mountain Water Resources’.…